Inflammatory mediators in Escherichia coli-induced mastitis in mice

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 31, Issue 6, 2008, Pages 551-565

  Notebaert, Sofie ^a   Demon, Dieter ^b   Vanden Berghe, Tom ^b   Vandenabeele, Peter ^b   Meyer, Evelyne ^a  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Acute phase reaction; Cytokines; Escherichia coli; Inflammation; Mouse mastitis model; NF B

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLIFORM BACTERIUM; CONTROLLED STUDY; ESCHERICHIA COLI; IMMUNE RESPONSE; INFLAMMATION; INOCULATION; KNOCKOUT MOUSE; MASTITIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UDDER; UPREGULATION; WILD TYPE;

ANIMALS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; INTERLEUKIN-1; INTERLEUKIN-1BETA; INTERLEUKIN-6; MAMMARY GLANDS, ANIMAL; MASTITIS; MICE; MICE, INBRED C57BL; NF-KAPPA B; SERUM AMYLOID A PROTEIN; TUMOR NECROSIS FACTOR-ALPHA;

ESCHERICHIA COLI; MUS;

EID: 55949084002     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2007.10.004     Document Type: Article

References (48)

1. Chandler R.L. Preliminary report on the production of experimental mastitis in the mouse. Vet Rec 84 (1969) 671-672
2. Chandler R.L. Experimental bacterial mastitis in the mouse. J Med Microbiol 3 (1970) 273-282
3. Notebaert S., and Meyer E. Mouse models to study the pathogenesis and control of bovine mastitis. A review. Vet Q 28 (2006) 2-13
4. Brouillette E., and Malouin F. The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes Infect 7 (2005) 560-568
5. Anderson J.C. The epidemiology and pathogenesis of experimental Staphylococcal and coliform mastitis in the mouse. Br Vet J 135 (1979) 163-171
6. Anderson J.C. The mouse mastitis model: observations relevant to the treatment and control of coliform mastitis. Vet Res Commun 7 (1983) 223-227
7. Anderson J.C., Burrows M.R., and Bramley A.J. Bacterial adherence in mastitis caused by Escherichia coli. Vet Pathol 14 (1977) 618-628
8. Anderson J.C. Absence of bacterial adherence in the establishment of experimental mastitis in mice. Vet Pathol 15 (1978) 770-775
9. Chandler R.L. Studies on experimental mouse mastitis relative to the assessment of pharmaceutical substances. J Comp Pathol 81 (1971) 507-514
10. Anderson J.C., and Craven N. Assessment in the mouse of cefoperazone as a treatment for mastitis. Vet Rec 114 (1984) 607-612
11. Yancey Jr. R.J., Kinney M.L., Roberts B.J., Goodenough K.R., Hamel J.C., and Ford C.W. Ceftiofur sodium, a broad-spectrum cephalosporin: evaluation in vitro and in vivo in mice. Am J Vet Res 48 (1987) 1050-1053
12. Cooray R., and Jonsson P. Modulation of resistance to mastitis pathogens by pretreatment of mice with T-2 toxin. Food Chem Toxicol 28 (1990) 687-692
13. Lee J.W., Paape M.J., and Zhao X. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice. Vet Res 34 (2003) 307-316
14. Mariathasan S., and Monack D.M. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7 (2007) 31-40
15. Bramley A.J. Variations in the susceptibility of lactating and non-lactating bovine udders to infection when infused with Escherichia coli. J Dairy Res 43 (1976) 205-211
16. Vangroenweghe F., Rainard P., Paape M., Duchateau L., and Burvenich C. Increase of Escherichia coli inoculum doses induces faster innate immune response in primiparous cows. J Dairy Sci 87 (2004) 4132-4144
17. Landegren U. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods 67 (1984) 379-388
18. Helle M., Boeije L., and Aarden L.A. Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol 18 (1988) 1535-1540
19. Burvenich C., Van Merris V., Mehrzad J., Diez-Fraile A., and Duchateau L. Severity of E. coli mastitis is mainly determined by cow factors. Vet Res 34 (2003) 521-564
20. Uhlar C.M., and Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265 (1999) 501-523
21. Jensen L.E., and Whitehead A.S. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J 334 (1998) 489-503
22. Cho K., Pham T.N., Crivello S.D., Jeong J., Green T.L., and Greenhalgh D.G. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury. Shock 21 (2004) 144-150
23. Martinez C., Juarranz Y., Abad C., Arranz A., Miguel B.G., Rosignoli F., et al. Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock. J Leukoc Biol 77 (2005) 729-738
24. Pyörälä S. Indicators of inflammation in the diagnosis of mastitis. Vet Res 34 (2003) 565-578
25. Petersen H.H., Nielsen J.P., and Heegaard P.M. Application of acute phase protein measurements in veterinary clinical chemistry. Vet Res 35 (2004) 163-187
26. Eckersall P.D., Young F.J., McComb C., Hogarth C.J., Safi S., Weber A., et al. Acute phase proteins in serum and milk from dairy cows with clinical mastitis. Vet Rec 148 (2001) 35-41
27. Jacobsen S., Niewold T.A., Kornalijnslijper E., Toussaint M.J., and Gruys E. Kinetics of local and systemic isoforms of serum amyloid A in bovine mastitic milk. Vet Immunol Immunopathol 104 (2005) 21-31
28. Lehtolainen T., Rontved C., and Pyörälä S. Serum amyloid A and TNF-α in serum and milk during experimental endotoxin mastitis. Vet Res 35 (2004) 651-659
29. Nielsen B.H., Jacobsen S., Andersen P.H., Niewold T.A., and Heegaard P.M. Acute phase protein concentrations in serum and milk from healthy cows, cows with clinical mastitis and cows with extramammary inflammatory conditions. Vet Rec 154 (2004) 361-365
30. Zheng J., Watson A.D., and Kerr D.E. Genome-wide expression analysis of lipopolysaccharide-induced mastitis in a mouse model. Infect Immun 74 (2006) 1907-1915
31. Abram M., Vu kD, Wraber B., and Doric M. Plasma cytokine response in mice with bacterial infection. Mediat Inflamm 9 (2000) 229-234
32. Nakajima Y., Mikami O., Yoshioka M., Motoi Y., Ito T., Ishikawa Y., et al. Elevated levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) activities in the sera and milk of cows with naturally occurring coliform mastitis. Res Vet Sci 62 (1997) 297-298
33. Hagiwara K., Yamanaka H., Hisaeda K., Taharaguchi S., Kirisawa R., and Iwai H. Concentrations of IL-6 in serum and whey from healthy and mastitic cows. Vet Res Commun 25 (2001) 99-108
34. Bannerman D.D., Paape M.J., Lee J.W., Zhao X., Hope J.C., and Rainard P. Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection. Clin Diagn Lab Immunol 11 (2004) 463-472
35. Lee J.W., Bannerman D.D., Paape M.J., Huang M.K., and Zhao X. Characterization of cytokine expression in milk somatic cells during intramammary infections with Escherichia coli or Staphylococcus aureus by real-time PCR. Vet Res 37 (2006) 219-229
36. Thornberry N.A., and Molineaux S.M. Interleukin-1 beta converting enzyme: a novel cysteine protease required for IL-1 beta production and implicated in programmed cell death. Protein Sci 4 (1995) 3-12
37. Shi Y. Caspase activation: revisiting the induced proximity model. Cell 117 (2004) 855-858
38. Long E., Capuco A.V., Wood D.L., Sonstegard T., Tomita G., Paape M.J., et al. Escherichia coli induces apoptosis and proliferation of mammary cells. Cell Death Differ 8 (2001) 808-816
39. Black R., Kronheim S., Sleath P., Greenstreet T., Virca G.D., March C., et al. The proteolytic activation of interleukin-1 β. Agents Actions Suppl 35 (1991) 85-89
40. Coeshott C., Ohnemus C., Pilyavskaya A., Ross S., Wieczorek M., Kroona H., et al. Converting enzyme-independent release of tumor necrosis factor-α and IL-1β from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci USA 96 (1999) 6261-6266
41. Rowe S.J., Allen L., Ridger V.C., Hellewell P.G., and Whyte M.K. Caspase-1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury. J Immunol 169 (2002) 6401-6407
42. Boulanger D., Bureau F., Mélotte D., Mainil J., and Lekeux P. Increased nuclear factor κB activity in milk cells of mastitis-affected cows. J Dairy Sci 86 (2003) 1259-1267
43. Akira S., and Takeda K. Toll-like receptor signaling. Nat Rev Immunol 4 (2004) 499-511
44. McDonald P.P., and Cassatella M.A. Activation of transcription factor NF-κB by phagocytic stimuli in human neutrophils. FEBS Lett 412 (1997) 583-586
45. Vollebregt M., Hampton M.B., and Winterbourn C.C. Activation of NF-κB in human neutrophils during phagocytosis of bacteria independently of oxidant generation. FEBS Lett 432 (1998) 40-44
46. McDonald P.P., Bald A., and Cassatella M.A. Activation of the NF-κB pathway by inflammatory stimuli in human neutrophils. Blood 89 (1997) 3421-3433
47. Hotta K., Niwa M., Hara A., Ohno T., Wang X., Matsuno H., et al. The loss of susceptibility to apoptosis in exudated tissue neutrophils is associated with their nuclear factor-κB activation. Eur J Pharmacol 433 (2001) 17-27
48. Pahl H.L. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18 (1999) 6853-6866